Brief: Cardiol Therapeutics To Commence Trading On Nasdaq Under Symbol "CRDL"
09/08/2021 16:32
Aug 9 (Reuters) - Cardiol Therapeutics Inc CRDL.TO :
* CARDIOL THERAPEUTICS TO COMMENCE TRADING ON NASDAQ UNDER THE SYMBOL "CRDL"
* CARDIOL THERAPEUTICS INC - CO'S COMMON SHARES WILL CONTINUE TO TRADE ON TORONTO STOCK
EXCHANGE
(TSX) UNDER SAME SYMBOL "CRDL"
* CARDIOL THERAPEUTICS INC - CONCURRENT WITH LISTING OF CARDIOL'S COMMON SHARES ON NASDAQ,
THE
SHARES WILL CEASE TO BE QUOTED ON OTCQX
Source text - https://bit.ly/3xxY59Q
Further company coverage: CRDL.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cardiol Therapeutics
See all newsBrief: Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead Of Schedule And Expands Pivotal Trial To Strengthen Assessment Of Cardiolrx's Efficacy
Brief: Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus
Brief: Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln
Brief: Cardiol Therapeutics Initiated Pivotal Phase Iii Maveric Trial Of Cardiolrx In Recurrent Pericarditis
NASDAQ RESUMED AT 09:00 AM